可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1]Hennersdorf F, Wellnhofer E, Musci M, et al. Aspects of cyclosporine A toxicity in the development of coronary artery disease in transplant recipients[J]. Transplant Proc, 2002, 34(4):1185-1188.
[2]姜鹏. 钙敏感受体参与MAPK通路诱导细胞凋亡信号传导通路的机制研究[J]. 齐齐哈尔医学院学报, 2007, 28(5):526-530.
[3]Miller LW. Cardiovascular toxicities of immunosuppressive agents[J]. Am J Transplant, 2002, 2(9):807-818.
[4]Sessa A, Esposito A, Giliberti A, et al. Immunosuppressive agents and metabolic factors of cardiovascular risk in renal transplant recipients[J]. Transplant Proc, 2009, 41(4):1178-1182.
[5]于金凤,李扬,张改改,等. 环胞霉素A致大鼠心肌组织损伤的实验研究[J]. 中国地方病学杂志, 2009, 28(4):413-416.
[6]Rezzani R, Rodella L, Dessy C, et al. Changes in Hsp90 expression determine the effects of cyclosporine a on the NO pathway in rat myocardium[J]. FEBS Lett, 2003, 552(2-3):125-129.
[7]Beanchi R, Rodella L, Rezzani R. Cyclosporine A up-regulates expession of matrix metalloproteinase 2 and vascular endothelial growth factor in rat heart[J]. Int Immunopharmacol, 2003, 3(3):427-433.
[8]Vassalle M, Lin CI. Calcium overload and cardiac function[J]. Biomed Sci, 2004, 11(5):542-565.
[9]徐长庆,王孝铭. 缺血-再灌注损伤[M]∥吴其夏,余应年,卢建. 病理生理学. 第2版. 北京: 中国协和医科大学出版社, 2003:279.